Literature DB >> 17445357

Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model.

Patrick Vollmar1, Aiden Haghikia, Rolf Dermietzel, Pedro M Faustmann.   

Abstract

Growing evidence indicates immunoregulatory effects of various antidepressants. Through the interaction of the nervous and immune systems, the norepinephrine-serotonin system was shown to modulate inflammatory CNS diseases. Thus, we examined the norepinephrine-serotonin reuptake inhibitor venlafaxine in an astroglia-microglia co-culture model which allows mimicking of an inflammatory milieu by increasing the cultured microglial fraction. Astrocytic membrane resting potential and intercellular coupling, two markers becoming severely impaired under inflammation, were assessed with the patch-clamp technique. We measured IL-6, IL-10, IFN-gamma and TGF-beta concentrations and analysed phenotypic changes of microglia. We found (i) a reversal of the inflammation-induced depolarization effect on the membrane resting potential, (ii) an augmentation of TGF-beta release with a concomitant reduction in the secretion of pro-inflammatory IL-6 and IFN-gamma, and (iii) a significant change of microglial phenotype from activated to resting morphology. Our data clearly indicate anti-inflammatory properties of venlafaxine which might be a result of monoamine-mediated immunomodulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445357     DOI: 10.1017/S1461145707007729

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  26 in total

1.  Paroxetine suppresses reactive microglia-mediated but not lipopolysaccharide-induced inflammatory responses in primary astrocytes.

Authors:  Xiong Zhang; Lan-Bing Zhu; Jia-Hui He; Hong-Qiu Zhang; Shu-Ya Ji; Chao-Nan Zhang; Na-Na Hou; Chen-Ping Huang; Jian-Hong Zhu
Journal:  J Neuroinflammation       Date:  2020-02-05       Impact factor: 8.322

2.  The effect of serotonin-noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats.

Authors:  Junichi Handa; Miho Sekiguchi; Olga Krupkova; Shin-Ichi Konno
Journal:  Eur Spine J       Date:  2015-09-22       Impact factor: 3.134

3.  Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture.

Authors:  A M Bielecka; M Paul-Samojedny; E Obuchowicz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-09-02       Impact factor: 3.000

Review 4.  Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?

Authors:  Karen Wager-Smith; Athina Markou
Journal:  Neurosci Biobehav Rev       Date:  2010-09-29       Impact factor: 8.989

5.  Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: Role of inflammatory cytokines and nitric oxide.

Authors:  Mohammad Taghi Mansouri; Bahareh Naghizadeh; Behnam Ghorbanzadeh; Neda Amirgholami; Gholamreza Houshmand; Soheila Alboghobeish
Journal:  Metab Brain Dis       Date:  2019-10-19       Impact factor: 3.584

6.  Dexamethasone differentially regulates functional membrane properties in glioma cell lines and primary astrocytes in vitro.

Authors:  Daniel Hinkerohe; Dörte Wolfkühler; Aiden Haghikia; Carola Meier; Pedro M Faustmann; Uwe Schlegel
Journal:  J Neurooncol       Date:  2010-11-24       Impact factor: 4.130

7.  Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats.

Authors:  Rosimary S Carvalho; Carolina M de Souza; Julliana C S Neves; Sergio A Holanda-Pinto; Lívia M S Pinto; Gerly A C Brito; Geanne M de Andrade
Journal:  J Negat Results Biomed       Date:  2010-06-14

Review 8.  TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease.

Authors:  Filippo Caraci; Giuseppe Battaglia; Valeria Bruno; Paolo Bosco; Viviana Carbonaro; Maria Laura Giuffrida; Filippo Drago; Maria Angela Sortino; Ferdinando Nicoletti; Agata Copani
Journal:  CNS Neurosci Ther       Date:  2009-11-19       Impact factor: 5.243

9.  Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Benjamin H Natelson; Diana Vu; Xiangling Mao; Nora Weiduschat; Fumiharu Togo; Gudrun Lange; Michelle Blate; Guoxin Kang; Jeremy D Coplan; Dikoma C Shungu
Journal:  J Pain       Date:  2015-08-31       Impact factor: 5.820

Review 10.  Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.

Authors:  Edward C Lauterbach
Journal:  Am J Neurodegener Dis       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.